Clarity Pharmaceuticals Ltd has released a press release.
App 4E Preliminary Final Report 30 June 2021
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
Later from Clarity Pharmaceuticals
- Recruitment closed on C-BOBCAT SAR-Bombesin trial
- Appendix 4C Cash Flow Report
- Dosimetry Recruitment of theranostic prostate trial complete
- Quarterly Activity Report
- Managing Directors Presentation to Annual General Meeting
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals